Atrial fibrillation trials recruiting in Arizona

All Atrial fibrillation trials nationally

Cities in Arizona

Recruiting trials in Arizona

• A Study Assessing Long-Term Safety and Effectiveness in Treatment Management of Atrial Fibrillation With VARIPULSE Catheter System
  NCT07227532 · Phase: Not applicable (e.g. observational or device study) · Ages: 22 Years and older · Sex: All (male and female) · Arizona: Phoenix, Tucson
• A Study of Assessment on Safety and Effectiveness of BWI Pulsed Field Ablation With OMNYPULSE Catheter for the Treatment of Paroxysmal Atrial Fibrillation (PAF)
  NCT06455098 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 80 Years · Sex: All (male and female) · Arizona: Phoenix
• A Study of VARIPULSE Catheter in Participants With Persistent Atrial Fibrillation Undergoing Pulmonary Vein and Superior Vena Cava Isolation
  NCT07527299 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 80 Years · Sex: All (male and female) · Arizona: Tucson
• Anticoagulation in ICH Survivors for Stroke Prevention and Recovery
  NCT03907046 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Arizona: Chandler, Phoenix, Tucson
• CardioFocus HeartLight Post-Approval Study
  NCT03168659 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · Arizona: Tucson
• Coherent Sine Burst Electroporation (CSE) Ablation System US IDE Study for Patients With Atrial Fibrillation
  NCT06784466 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 80 Years · Sex: All (male and female) · Arizona: Phoenix
• Real-world Experience of Catheter Ablation for the Treatment of Arrhythmias
  NCT04088071 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · Arizona: Chandler, Tucson
• Safety and Efficacy of Workflows of High Volume Single Operators in a LAAO Device Implant Procedural Day
  NCT06436924 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · Arizona: Tucson
• Semaglutide for Metabolic Intervention and Adipose Loss to Treat Atrial Fibrillation
  NCT06499857 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female) · Arizona: Phoenix
• Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation
  NCT07626411 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Arizona: Glendale
• Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
  NCT05712200 · Phase: Phase 3 · Ages: 65 Years and older · Sex: All (male and female) · Arizona: Gilbert, Peoria, Phoenix, Yuma
• The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation
  NCT05836987 · Phase: Phase 3 · Ages: 22 Years to 85 Years · Sex: All (male and female) · Arizona: Phoenix